NYSE:ABTMedical Equipment
Abbott (ABT) Stock May Be 32% Undervalued As Legal Overhang Fades
Abbott Laboratories stock has rebounded sharply in recent weeks after a tough start to the year, and both the Discounted Cash Flow (DCF) intrinsic value estimate and earnings multiple checks currently point to the shares trading at a discount to what the business may be worth.
Year to date the share price is still down 19.7%, which means the recent rally has not fully erased earlier losses and may leave room if the current valuation gap closes.
On the upside, expectations around higher...